Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Think you are allergic to penicillin? There is a 90 per cent chance you may not be anymore
Penicillin, the first natural antibiotic discovered by Alexander Fleming in 1928.
Biosensor-equipped glasses could monitor diabetes through tears
Brazilian and US scientists have developed a glasses-based biosensor capable of measuring blood glucose levels through a person’s tears, offering a less invasive test for diabetics.
Screening tech advances early detection of Parkinson’s disease
Screening technology to catch Parkinson’s disease in its earliest stages could be available within three years, following an agreement between RMIT University and start-up company Jesse Medical.
Biocon gets US FDA approval for new facility in Bengaluru
The US Food and Drug Administration (FDA) has approved Biocon Ltd's new facility at Bengaluru for the manufacturing of pegfilgrastim biosimilar Fulphila, the company said in a release toda...
AstraZeneca's Imfinzi gets speedy FDA review for small cell lung cancer
(Reuters) - British drugmaker AstraZeneca Plc said on Friday its immunotherapy cancer treatment Imfinzi has been granted a speedy review by the U.
Home urine test could revolutionise prostate cancer diagnosis
Dr Jeremy Clark, from University of East Anglia's Norwich Medical School, has said the move could "revolutionise diagnosis".
In a first for cell biology, scientists observe ribosome assembly in real time
A team of scientists from Scripps Research and Stanford University has recorded in real time a key step in the assembly of ribosomes—the complex and evolutionarily ancient "molecular machines&q...
Popular heartburn drugs may up odds of stomach bug
(HealthDay)—If you're one of the millions who rely on medications known as proton pump inhibitors for relief from heartburn, you may be at higher risk of illness from a stomach bug, new ...
FDA accepts Incyte’s NDA for priority review of pemigatinib to treat cholangiocarcinoma
The US Food and Drug Administration (FDA) has accepted Incyte’s new drug application (NDA) for the priority review of its pemigatinib to treat patients with cholangiocarcinoma.
One shot of ketamine could reduce problem drinking
A one-off dose of ketamine could help heavy drinkers reduce their alcohol intake, finds a new UCL experimental study.
Asahi Kasei Unveils Deal to Buy Veloxis for $1.3 Billion
Asahi Kasei Corp.
Teva partners with Israeli institutes for early-stage drug research
JERUSALEM (Reuters) - Teva Pharmaceutical Industries on Monday signed research agreements with two leading Israeli academic institutes, a move to boost its early-stage drug development with a ...
378
379
380
381
382
383
384
385
386